FEDERATED HERMES, INC. - TRAVERE THERAPEUTICS INC ownership

TRAVERE THERAPEUTICS INC's ticker is TVTX and the CUSIP is 89422G107. A total of 151 filers reported holding TRAVERE THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 0.60 and the average weighting 0.1%.

Quarter-by-quarter ownership
FEDERATED HERMES, INC. ownership history of TRAVERE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$871,570
+4150233.3%
97,491
+9749000.0%
0.00%
Q4 2022$21
-99.9%
1
-99.9%
0.00%
Q3 2022$30,000
+50.0%
1,199
+53.7%
0.00%
Q2 2022$20,000
-99.1%
780
-99.1%
0.00%
-100.0%
Q1 2022$2,241,000
+41.2%
86,934
+70.1%
0.01%
+66.7%
Q4 2021$1,587,000
+1988.2%
51,112
+1527.3%
0.00%
Q3 2021$76,000
-92.2%
3,141
-95.3%
0.00%
-100.0%
Q2 2021$969,000
-87.7%
66,398
-78.9%
0.00%
-86.7%
Q1 2021$7,861,000
+8.7%
314,817
+18.7%
0.02%0.0%
Q4 2020$7,229,000265,2340.02%
Other shareholders
TRAVERE THERAPEUTICS INC shareholders Q1 2021
NameSharesValueWeighting ↓
GREAT POINT PARTNERS LLC 1,084,300$15,820,0003.32%
ARMISTICE CAPITAL, LLC 5,748,000$83,863,0001.50%
RA Capital Management 5,614,428$81,915,0001.32%
Krensavage Asset Management, LLC 140,000$2,043,0000.69%
CM Management, LLC 60,000$875,0000.63%
Altium Capital Management LP 170,484$2,487,0000.58%
HighVista Strategies LLC 53,498$781,0000.55%
Sio Capital Management, LLC 150,000$2,189,0000.54%
MANGROVE PARTNERS IM, LLC 295,037$4,305,0000.44%
Rock Springs Capital Management LP 1,494,164$21,800,0000.43%
View complete list of TRAVERE THERAPEUTICS INC shareholders